Trial Shows Lilly’s Lebrikizumab Produces Improvements in Atopic Dermatitis Severity, Particularly in Individuals with Skin of Color

First of its kind study reported major improvements in skin clarity and itch relief in over two-thirds of participants.

Source link
#Trial #Shows #Lillys #Lebrikizumab #Produces #Improvements #Atopic #Dermatitis #Severity #Individuals #Skin #Color